Titan Pharmaceuticals, Inc. (TTNP) Reports Q3 Loss of $0.01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TTNP Hot Sheet
Join SI Premium – FREE
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) reported Q3 EPS of ($0.01), versus ($0.01) reported last year. Revenue for the quarter came in at $1.01 million, versus $3.6 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Real Industry (RELY) Tops Q3 EPS by 15c; offers guidance
- Suncor Energy (SU) Tops Q3 EPS by 172c
- MGIC Investment (MTG) Tops Q3 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
